Wearable artificial kidney and wearable ultrafiltration device vascular access-future directions

Background: Since 2005, three human clinical trials have been performed with the Wearable Artificial Kidney (WAK) and Wearable Ultrafiltration (WUF) device. The lack of an adequate vascular access (VA) has been pointed out as the main limitation to their implementation. Based on the current level of...

Full description

Bibliographic Details
Main Author: Castro, Ana (author)
Other Authors: Neri, M. (author), Nayak Karopadi, A. (author), Lorenzin, A. (author), Marchionna, N. (author), Ronco, C. (author)
Format: article
Language:eng
Published: 2020
Subjects:
end-stage renal disease
renal replacement therapy
vascular access
wearable artificial kidney
wearable ultrafiltration device
Online Access:http://hdl.handle.net/10400.16/2368
Country:Portugal
Oai:oai:repositorio.chporto.pt:10400.16/2368

Internet

http://hdl.handle.net/10400.16/2368

Similar Items